Progress in Mind Go to Progress in Mind Main channel featuring interviews, articles, congress highlights and much more. Go to channel
Schizofreni Expert Views The concept of life engagement in schizophrenia Professor Andrea Fagiolini sat down with us at ECNP 2021 to talk about the concept of patient... Content action menuShareTestTest 2Test 3
Depression, Schizofreni Expert Views Patient life engagement in MDD and Schizophrenia Professor Roger McIntyre sat down with us to talk about patient life engagement for people... Content action menuShareTestTest 2Test 3
Schizofreni Expert Views How best to track and manage long-term functional recovery in patients with schizophrenia At ECNP 2021, Dr Charlotte Emborg chatted about how it is essential to have a healthcare system... Content action menuShareTestTest 2Test 3
Schizofreni Expert Views Measuring patient life engagement in schizophrenia in clinical trials and clinical practice Professor Andrea Fagiolini sat down with us at ECNP 2021 to discuss how patient life engagement in... Content action menuShareTestTest 2Test 3
Schizofreni Expert Views Functional recovery: Beyond symptom control Dr Charlotte Emborg sat down with us at ECNP 2021 to talk about functional recovery in... Content action menuShareTestTest 2Test 3
Schizofreni Expert Views Patient life engagement is a long term, collaborative goal Patient life engagement practices mean bringing a person with schizophrenia to a point where they... Content action menuShareTestTest 2Test 3
Depression Lästid: 2 minut(s) Article What are the implications of childhood trauma for depression and its response to therapy? Childhood trauma is an important risk factor for major depressive disorder (MDD).1 It is... Content action menuShareTestTest 2Test 3
Schizofreni Lästid: 2 minut(s) Satellite symposium Improving positive and negative symptoms with dopamine D2 partial agonists Dopamine D2 partial agonists can ameliorate both positive and negative symptoms of schizophrenia... Content action menuShareTestTest 2Test 3
Schizofreni Lästid: 2 minut(s) Satellite symposium Long-acting injectable antipsychotics in clinical practice For patients with schizophrenia, appropriate use of long-acting injectable antipsychotics lowers... Content action menuShareTestTest 2Test 3
Depression, Schizofreni Lästid: 3 minut(s) Congress highlights Measurement-based care: How can we improve outcomes for patients with depression and schizophrenia Measurement-based care (MBC) can improve outcomes and reduce health disparities for serious mental... Content action menuShareTestTest 2Test 3
Depression Lästid: 4 minut(s) Satellite symposium From response and remission to full functional recovery in major depressive disorder: Is patient-involvement the missing link? Depression is a common and serious illness with heterogeneous symptoms within emotional, physical... Content action menuShareTestTest 2Test 3
Schizofreni Lästid: 3 minut(s) Congress highlights Better safe than sorry? Knowns and unknowns in the maintenance treatment of remitted first-episode psychotic disorders Psychotic disorders, including schizophrenia and related disorders, which affect up to 3% of the... Content action menuShareTestTest 2Test 3